TEST vs. MRNY
TEST (YieldMax TSLA Performance & Distribution Target 25 ETF) and MRNY (YieldMax MRNA Option Income Strategy ETF) are both Derivative Income funds from YieldMax. Both are actively managed. At a 0.20 correlation, their price movements are largely independent. TEST charges 1.01%/yr vs 0.99%/yr for MRNY.
Performance
TEST vs. MRNY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEST achieves a -10.90% return, which is significantly lower than MRNY's 73.87% return.
TEST
- 1D
- -0.24%
- 1M
- -9.29%
- YTD
- -10.90%
- 6M
- -16.29%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MRNY
- 1D
- -0.53%
- 1M
- 19.78%
- YTD
- 73.87%
- 6M
- 58.68%
- 1Y
- 67.82%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TEST vs. MRNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TEST YieldMax TSLA Performance & Distribution Target 25 ETF | -10.90% | 8.46% |
MRNY YieldMax MRNA Option Income Strategy ETF | 73.87% | 8.07% |
Correlation
The correlation between TEST and MRNY is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 18, 2025 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEST vs. MRNY — Risk / Return Rank
TEST
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
MRNY
TEST vs. MRNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for YieldMax TSLA Performance & Distribution Target 25 ETF (TEST) and YieldMax MRNA Option Income Strategy ETF (MRNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TEST | MRNY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.25 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.16 | — |
| Martin ratioReturn relative to average drawdown | — | 4.18 | — |
Loading charts...
Drawdowns
TEST vs. MRNY - Drawdown Comparison
The maximum TEST drawdown since its inception was -23.35%, smaller than the maximum MRNY drawdown of -82.15%. Use the drawdown chart below to compare losses from any high point for TEST and MRNY.
Loading charts...
Drawdown Indicators
| TEST | MRNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.35% | -82.15% | +58.80% |
Max Drawdown (1Y)Largest decline over 1 year | — | -31.53% | — |
Current DrawdownCurrent decline from peak | -16.74% | -63.40% | +46.66% |
Average DrawdownAverage peak-to-trough decline | -10.56% | -52.89% | +42.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 16.26% | — |
Volatility
TEST vs. MRNY - Volatility Comparison
Loading charts...
Volatility by Period
| TEST | MRNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 15.79% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 38.77% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 33.30% | 50.99% | -17.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.30% | 50.97% | -17.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.30% | 50.97% | -17.67% |
TEST vs. MRNY - Expense Ratio Comparison
TEST has a 1.01% expense ratio, which is higher than MRNY's 0.99% expense ratio.
Dividends
TEST vs. MRNY - Dividend Comparison
TEST's dividend yield for the trailing twelve months is around 16.58%, less than MRNY's 87.35% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
MRNY YieldMax MRNA Option Income Strategy ETF | 87.35% | 145.98% | 178.49% | 1.75% |
TEST YieldMax TSLA Performance & Distribution Target 25 ETF | 16.58% | 2.50% | 0.00% | 0.00% |
Frequently Asked Questions
TEST and MRNY have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, MRNY is cheaper at 0.99% per year. The better choice depends on whether you care most about return, fees, risk, or income.
MRNY is cheaper with a 0.99% expense ratio, compared with 1.01% for TEST.
MRNY has the higher dividend yield at 87.35%, compared with 16.58% for TEST.
Their fees differ too: 1.01% for TEST and 0.99% for MRNY.
Find the right allocation for TEST and MRNY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer